Healthware has launched a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.
The COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to engage with healthcare professionals (HCPs) and other stakeholders.
Digital transformation has long been a priority for all life science companies and it has been made even more pressing by the current health emergency caused by COVID-19.
Digital transformation; it would be easy to assume that it is widespread across the life science industry, and yet while it is true to say that every company in the sector will have made inroads in